scPharmaceuticals Inc. (SCPH)
NASDAQ: SCPH
· Real-Time Price · USD
4.60
-0.35 (-7.07%)
At close: Aug 15, 2025, 3:59 PM
4.74
3.04%
After-hours: Aug 15, 2025, 07:07 PM EDT
scPharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 40.81M | 57.54M | 75.66M | 91.48M | 38.5M | 58.45M | 46.81M | 35.04M | 71.35M | 75.45M | 71.06M | 41.29M | 41.18M | 51.63M | 74.27M | 79.32M | 74.97M | 75.84M |
Short-Term Investments | n/a | 354K | 1.02M | 1.15M | 373K | 536K | 29.2M | 55.16M | 31.53M | 40.62M | 47.13M | 3.9M | 14.67M | 13.79M | 1.01M | 5.51M | 15.05M | 20.49M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 182K | 182K | n/a | n/a | 182K | 182K | 182K |
Other Long-Term Assets | 303K | 322K | 341K | 359K | 1.47M | 522K | 82K | 188K | 189K | 190K | 267K | 310K | 283K | 283K | 283K | 289K | 248K | 243K |
Receivables | 19.41M | 13.85M | 11.72M | 9.22M | 6.12M | 5.77M | 4.49M | 4.17M | 1.61M | 3M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 14.57M | 14.14M | 13.9M | 18.11M | 15.31M | 9.57M | 8.84M | 7.12M | 5.83M | 3.62M | 1.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.94M | 354K | 1.02M | 1.15M | 373K | 536K | 1.16M | 1.26M | 1.42M | 1.29M | 182K | 340K | 331K | 241K | 182K | 11K | 75K | 102K |
Total Current Assets | 78.73M | 89.35M | 105.85M | 123.33M | 62.63M | 76.53M | 92.94M | 104.34M | 113.57M | 126.67M | 123.31M | 47.17M | 57.85M | 68.23M | 78.28M | 86.47M | 92.49M | 99.07M |
Property-Plant & Equipment | 1.22M | 1.29M | 1.33M | 1.38M | 1.36M | 1.41M | 1.46M | 1.57M | 408K | 514K | 620K | 739K | 842K | 384K | 479K | 590K | 693K | 802K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 1.53M | 1.61M | 1.67M | 1.74M | 2.83M | 1.93M | 1.54M | 1.76M | 597K | 704K | 887K | 1.23M | 1.31M | 667K | 762K | 1.06M | 1.12M | 1.23M |
Total Assets | 80.25M | 90.96M | 107.52M | 125.07M | 65.46M | 78.45M | 94.48M | 106.1M | 114.17M | 127.37M | 124.19M | 48.4M | 59.16M | 68.89M | 79.04M | 87.53M | 93.61M | 100.29M |
Account Payables | 4.03M | 4.99M | 3.88M | 5M | 5.29M | 2.71M | 4M | 3.37M | 1.18M | 1.63M | 1.52M | 996K | 982K | 445K | 544K | 447K | 531K | 753K |
Deferred Revenue | n/a | 945K | n/a | n/a | n/a | n/a | n/a | n/a | 5.12M | n/a | n/a | n/a | n/a | n/a | 4M | 3.46M | 3.54M | n/a |
Short-Term Debt | 264K | n/a | n/a | 231K | 190K | 184K | 176K | 248K | 267K | n/a | n/a | 10.47M | 10.4M | 10.18M | 9.8M | 10.27M | 7.78M | 5.31M |
Other Current Liabilities | 12M | 3.17M | 5.57M | 4.08M | 4.06M | 38K | 30K | 152K | 2.17M | 252K | 42K | 2.98M | 2.19M | 2.44M | 2.87M | 453K | 555K | 2.37M |
Total Current Liabilities | 20.43M | 16.31M | 14.88M | 15.26M | 12.93M | 12.32M | 13.13M | 10.95M | 6.63M | 7.74M | 7.42M | 17.18M | 15.54M | 14.18M | 14.85M | 14.21M | 11.89M | 9.65M |
Long-Term Debt | 52.18M | 51.05M | 51.35M | 51.1M | 39.99M | 39.38M | 38.81M | 38.26M | 37.74M | 37.25M | 36.79M | n/a | 2.46M | 4.91M | 7.35M | 9.78M | 12.16M | 14.52M |
Other Long-Term Liabilities | 28.96M | 27.68M | 26.87M | 26.83M | 2.1M | 952K | 4.03M | 6.44M | 6.36M | 6.57M | 7.54M | n/a | 431K | 402K | 367K | 340K | 299K | 259K |
Total Long-Term Liabilities | 81.14M | 79.78M | 79.32M | 79.1M | 43.28M | 41.57M | 44.13M | 46M | 44.11M | 43.83M | 44.35M | 114K | 3.17M | 5.33M | 7.72M | 10.22M | 12.68M | 15.13M |
Total Liabilities | 101.57M | 96.09M | 94.2M | 94.36M | 56.21M | 53.89M | 57.26M | 56.95M | 50.74M | 51.56M | 51.76M | 17.29M | 18.7M | 19.5M | 22.57M | 24.42M | 24.57M | 24.78M |
Total Debt | 52.45M | 52.36M | 52.69M | 52.5M | 41.36M | 40.8M | 40.27M | 39.81M | 38.01M | 37.68M | 37.37M | 10.59M | 13.14M | 15.11M | 17.64M | 20.15M | 20.16M | 20.18M |
Common Stock | 5K | 5K | 5K | 5K | 4K | 4K | 4K | 4K | 4K | 4K | 3K | 3K | 3K | 3K | 3K | 3K | 3K | 3K |
Retained Earnings | -404.26M | -386.24M | -366.49M | -347.65M | -312.54M | -295.45M | -281.35M | -267.53M | -251.9M | -237.75M | -226.54M | -217.29M | -207.13M | -197.43M | -189.7M | -182.38M | -175.83M | -168.77M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -2K | -6K | 8K | 32K | n/a | -7K | -4K | -1K | n/a | 0.00 | -1K |
Shareholders Equity | -21.32M | -5.13M | 13.32M | 30.71M | 9.25M | 24.57M | 37.22M | 49.15M | -251.9M | -237.75M | -226.54M | 31.11M | 40.46M | 49.39M | 56.47M | 63.11M | 69.04M | 75.52M |
Total Investments | n/a | 354K | 1.02M | 1.15M | 373K | 536K | 29.2M | 55.16M | 31.53M | 40.62M | 47.13M | 3.9M | 14.67M | 13.79M | 1.01M | 5.51M | 15.05M | 20.49M |